Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  22nd Century Group       

22ND CENTURY GROUP
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

22nd Century : The Briefcase The Briefcase

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/14/2017 | 09:45am CEST

22nd Century Group CEO

to speak at tobacco forum

22nd Century Group Inc., a plant biotechnology company with a production plant in Mocksville, said that Henry Sicignano III, its chief executive, will speak at today's Global Tobacco & Nicotine Forum in New York City.

Sicignano will participate on a panel discussing future next-generation products.

The forum is noted for its exchange of global ideas and information for tobacco technologies and products. Attendees to the forum include public health advocates, policymakers, scientists and industry executives.

22nd Century, based in Clarence, N.Y., bought the cigarette-manufacturing equipment of defunct Renegade Tobacco Co. in 2013 for $3.22 million in a bankruptcy proceeding.

Richard Craver

Triad HealthCare Network adds medical directors

Triad HealthCare Network said Wednesday it has added Drs. Beth Hodges and Rob Reade as medical directors to its primary care division.

The network is a partnership between area health-care providers and Cone Health.

Cone said the doctors will provide "a physician's perspective in developing the network's various quality and savings initiatives."

Hodges is a family medicine doctor at Hodges Family Practice in Asheville. Reade is a family medicine doctor at Eagle Family Medicine @ Triad. Both will continue seeing patients.

Richard Craver

Lexington Dialysis Center gets state OK for facility

Lexington Dialysis Center has received conditional approval from state health regulators for its certificate-of-need application.

The group has applied to spend $4.72 million on building a new facility on the same site at 233 Anna Lewis Drive.

The group is affiliated with Wake Forest Baptist Medical Center.

High Point pharmaceutical company plans IPO

Axium Pharmaceuticals Inc., based in High Point, has submitted a regulatory filing for a proposed initial public offering of its Class A common stock.

The company plans to sell 50 million shares, while shareholders plan to sell 45.13 million shares. There is no underwriter of the IPO.

The asking price is projected to be 10 cents a share, with potential gross proceeds of $9.51 million, including $5 million for use by the corporation.

Axium focuses on utilizing drug delivery innovations for developing improved novel formulations and alternative dosage forms of existing biologically active molecules. Product candidates address various pharmaceutical markets, including neurological disorderss, infectious diseases and diabetes.

Richard Craver

© © Copyright 2017, Winston-Salem Journal, Winston-Salem, NC, source Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on 22ND CENTURY GROUP
06/2122ND CENTURY : to be Added to Russell 2000, Russell 3000, and Russell Global Ind..
AQ
06/2122ND CENTURY : Group studying low-nicotine products 22nd Century Group begins st..
AQ
06/2022ND CENTURY : Conducts Three Short-Term Studies in Support of the Company&rsquo..
BU
06/1322ND CENTURY : to be Added to Russell 2000, Russell 3000, and Russell Global Ind..
BU
06/0722ND CENTURY : Altria, Reynolds, Lorillard, and Philip Morris Ordered to Issue C..
AQ
06/0422ND CENTURY : to Present to Institutional Investors at the Citi 2018 Small & Mi..
BU
05/3122ND CENTURY : Public Health Leaders Urge FDA to Issue Final Rule for Reducing N..
AQ
05/2922ND CENTURY : Altria, Reynolds, Lorillard, and Philip Morris Ordered to Issue C..
BU
05/2422ND CENTURY : Public Health Leaders Urge FDA to Issue Final Rule for Reducing N..
BU
05/2422ND CENTURY : Public Health Leaders Urge FDA to Issue Final Rule for Reducing N..
BU
More news
News from SeekingAlpha
01/23Short seller takes aim at 22nd Century Group 
01/22260 MARIJUANA STOCKS : Equal-Weighted Portfolio Up Nearly 7% For The Week Ending.. 
01/21WEEK 4 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
01/1822nd Century Group builds on rally, up 11% 
01/16How To Find The Hottest Sectors For 2018 In The Coldest Part Of The Year 
Financials ($)
Sales 2018 18,1 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 14,9x
Capi. / Sales 2019 13,5x
Capitalization 270 M
Chart 22ND CENTURY GROUP
Duration : Period :
22nd Century Group Technical Analysis Chart | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,5 $
Spread / Average Target 437%
Managers
NameTitle
Henry Sicignano President, Chief Executive Officer & Director
James W. Cornell Chairman
John T. Brodfuehrer CFO, Treasurer & Principal Accounting Officer
Juan Sanchez Tamburrino Vice President-Research & Development
Joseph Alexander Dunn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
22ND CENTURY GROUP37.86%270
WASTE MANAGEMENT-4.19%35 749
REPUBLIC SERVICES2.29%22 680
WASTE CONNECTIONS INC12.95%19 993
UMICORE25.26%14 192
SUEZ ENVIRONNEMENT-21.28%8 215